BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 19362364)

  • 1. The cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering.
    Pytlík R; Stehlík D; Soukup T; Kalbácová M; Rypácek F; Trc T; Mulinková K; Michnová P; Kideryová L; Zivný J; Klener P; Veselá R; Trnený M; Klener P
    Biomaterials; 2009 Jul; 30(20):3415-27. PubMed ID: 19362364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering.
    Siddappa R; Licht R; van Blitterswijk C; de Boer J
    J Orthop Res; 2007 Aug; 25(8):1029-41. PubMed ID: 17469183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced engraftment of mesenchymal stem cells in a cutaneous wound model by culture in allogenic species-specific serum and administration in fibrin constructs.
    Gregory CA; Reyes E; Whitney MJ; Spees JL
    Stem Cells; 2006 Oct; 24(10):2232-43. PubMed ID: 16763199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Xenogeneic protein free cultivation of mesenchymal multipotent stromal cells].
    Stehlík D; Pytlík R; Rychtrmocová H; Veselá R; Kopečný Z; Trč T
    Acta Chir Orthop Traumatol Cech; 2011; 78(6):537-43. PubMed ID: 22217407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro initial expansion of mesenchymal stem cells is influenced by the culture parameters used in the isolation process.
    Chen HH; Decot V; Ouyang JP; Stoltz JF; Bensoussan D; de Isla NG
    Biomed Mater Eng; 2009; 19(4-5):301-9. PubMed ID: 20042797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute.
    Bernardo ME; Avanzini MA; Perotti C; Cometa AM; Moretta A; Lenta E; Del Fante C; Novara F; de Silvestri A; Amendola G; Zuffardi O; Maccario R; Locatelli F
    J Cell Physiol; 2007 Apr; 211(1):121-30. PubMed ID: 17187344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
    Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
    Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
    Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
    Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow.
    Poloni A; Maurizi G; Rosini V; Mondini E; Mancini S; Discepoli G; Biasio S; Battaglini G; Felicetti S; Berardinelli E; Serrani F; Leoni P
    Cytotherapy; 2009; 11(2):153-62. PubMed ID: 19301169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability.
    Shahdadfar A; Frønsdal K; Haug T; Reinholt FP; Brinchmann JE
    Stem Cells; 2005 Oct; 23(9):1357-66. PubMed ID: 16081661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine.
    Lange C; Cakiroglu F; Spiess AN; Cappallo-Obermann H; Dierlamm J; Zander AR
    J Cell Physiol; 2007 Oct; 213(1):18-26. PubMed ID: 17458897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue.
    Kocaoemer A; Kern S; Klüter H; Bieback K
    Stem Cells; 2007 May; 25(5):1270-8. PubMed ID: 17255520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera?
    Tonti GA; Mannello F
    Int J Dev Biol; 2008; 52(8):1023-32. PubMed ID: 18956335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of neuroectodermal differentiation capacity of human bone marrow stromal cells using various conversion protocols.
    Hermann A; Liebau S; Gastl R; Fickert S; Habisch HJ; Fiedler J; Schwarz J; Brenner R; Storch A
    J Neurosci Res; 2006 Jun; 83(8):1502-14. PubMed ID: 16612831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural differentiation of human mesenchymal stem cells: Evidence for expression of neural markers and eag K+ channel types.
    Mareschi K; Novara M; Rustichelli D; Ferrero I; Guido D; Carbone E; Medico E; Madon E; Vercelli A; Fagioli F
    Exp Hematol; 2006 Nov; 34(11):1563-72. PubMed ID: 17046576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells.
    Solchaga LA; Penick K; Porter JD; Goldberg VM; Caplan AI; Welter JF
    J Cell Physiol; 2005 May; 203(2):398-409. PubMed ID: 15521064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies.
    Warnke PH; Humpe A; Strunk D; Stephens S; Warnke F; Wiltfang J; Schallmoser K; Alamein M; Bourke R; Heiner P; Liu Q
    J Craniomaxillofac Surg; 2013 Mar; 41(2):153-61. PubMed ID: 22878221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovine bone- and marrow-derived progenitor cells and their potential for scaffold-based bone tissue engineering applications in vitro and in vivo.
    Reichert JC; Woodruff MA; Friis T; Quent VM; Gronthos S; Duda GN; Schütz MA; Hutmacher DW
    J Tissue Eng Regen Med; 2010 Oct; 4(7):565-76. PubMed ID: 20568083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of mesenchymal stromal cells on mineralized collagen leads to ectopic matrix synthesis in vivo independently from prior in vitro differentiation.
    Niemeyer P; Kasten P; Simank HG; Fellenberg J; Seckinger A; Kreuz PC; Mehlhorn A; Südkamp NP; Krause U
    Cytotherapy; 2006; 8(4):354-66. PubMed ID: 16923611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.
    Pérez-Ilzarbe M; Díez-Campelo M; Aranda P; Tabera S; Lopez T; del Cañizo C; Merino J; Moreno C; Andreu EJ; Prósper F; Pérez-Simón JA
    Transfusion; 2009 Sep; 49(9):1901-10. PubMed ID: 19497059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.